Table 1.
Increased abundance or expression in primary tumor |
Increased abundance or expression in BM |
Decreased abundance or expression in BM |
---|---|---|
CD4+ T cells | Mutations in STK11, FAM129C, ADAMTS, and APOBEC signature | Th1 and CD8 T genes |
CD8+ T cells | TMB | Expression of VCAM1 |
CD+ FOXP3 | Higher number of somatic mutations | Leukocyte extravasation signaling |
PD-L1 expression* | Higher variant allelic frequency of mutated genes. | Th1 immune response |
Invasion, metastasis, and metabolic-associated pathways | Reduced T cell heterogeneity | |
Alterations in Hippo pathway | Dendritic cell maturation | |
PD-L1 expression* | CD8+ T cells | |
Macrophages (not TAMs) | ||
CTLA-4 |
*Discordant results.